Cardiac Dysfunction in Critically Ill Patients With COVID-19

NCT04524234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2020-12-24

No results posted yet for this study

Summary

Cardiac dysfunction has been reported to be common in patients infected with COVID-19. The aim of this study is to evaluate the clinical importance of cardiac dysfunction in critically ill patients infected with COVID-19.

Conditions

  • Covid19
  • Left Ventricular Dysfunction
  • Right Ventricular Dysfunction
  • Pulmonary Hypertension

Interventions

DIAGNOSTIC_TEST

Echocardiography

Echocardiography for assessment of cardiac function

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Jonatan Oras, MD, PhD · Sahlgrenska University Hospital

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2020-08-31
Completion
2020-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04524234 on ClinicalTrials.gov